Given that p53 accumulation in erythroid precursors is responsible for the hypoplastic anemia in del(5q) MDS, targeting p53 directly could restore terminal differentiation and effective erythropoiesis in the del(5q) clone. The gene discussed is TP53; the disease is myelodysplastic syndrome.